

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | barbed-end actin filament capping (GO:0051016) | 4.90895361 |
| 2 | keratan sulfate catabolic process (GO:0042340) | 4.58397938 |
| 3 | amino sugar catabolic process (GO:0046348) | 4.51896469 |
| 4 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.51836770 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.21830597 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17467043 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17467043 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.17467043 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17467043 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.17467043 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17467043 |
| 12 | glial cell migration (GO:0008347) | 4.15856990 |
| 13 | adenosine receptor signaling pathway (GO:0001973) | 3.96130703 |
| 14 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.84365640 |
| 15 | glycolipid catabolic process (GO:0019377) | 3.81100032 |
| 16 | cellular response to cadmium ion (GO:0071276) | 3.79912184 |
| 17 | apoptotic cell clearance (GO:0043277) | 3.70747447 |
| 18 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69466487 |
| 19 | chondroitin sulfate catabolic process (GO:0030207) | 3.61102343 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 3.58216651 |
| 21 | heart trabecula formation (GO:0060347) | 3.54321233 |
| 22 | oligosaccharide catabolic process (GO:0009313) | 3.49884260 |
| 23 | positive regulation of cholesterol efflux (GO:0010875) | 3.47995421 |
| 24 | regulation of fever generation (GO:0031620) | 3.46082751 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42821016 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.42604501 |
| 27 | extracellular fibril organization (GO:0043206) | 3.41578121 |
| 28 | negative regulation of platelet activation (GO:0010544) | 3.40979240 |
| 29 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 3.38426982 |
| 30 | vitamin A metabolic process (GO:0006776) | 3.34884296 |
| 31 | response to pheromone (GO:0019236) | 3.34262702 |
| 32 | axon extension involved in axon guidance (GO:0048846) | 3.31664615 |
| 33 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.31664615 |
| 34 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.29325535 |
| 35 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 3.27259788 |
| 36 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.27051054 |
| 37 | positive regulation of cholesterol transport (GO:0032376) | 3.26379561 |
| 38 | positive regulation of sterol transport (GO:0032373) | 3.26379561 |
| 39 | ceramide catabolic process (GO:0046514) | 3.25230264 |
| 40 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.24245619 |
| 41 | regulation of cholesterol storage (GO:0010885) | 3.23758744 |
| 42 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16932839 |
| 43 | positive regulation of lipid kinase activity (GO:0090218) | 3.15698233 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.15024304 |
| 45 | positive regulation of adherens junction organization (GO:1903393) | 3.13025721 |
| 46 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.12230798 |
| 47 | positive regulation of macrophage cytokine production (GO:0060907) | 3.11239147 |
| 48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.10153535 |
| 49 | protein carboxylation (GO:0018214) | 3.10153535 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.09643844 |
| 51 | fibril organization (GO:0097435) | 3.08641700 |
| 52 | sprouting angiogenesis (GO:0002040) | 3.07375538 |
| 53 | positive regulation of cell junction assembly (GO:1901890) | 3.07117463 |
| 54 | positive regulation of focal adhesion assembly (GO:0051894) | 3.07117463 |
| 55 | mannose metabolic process (GO:0006013) | 3.06637861 |
| 56 | endothelial cell proliferation (GO:0001935) | 3.06593811 |
| 57 | endothelium development (GO:0003158) | 3.05151792 |
| 58 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.99184984 |
| 59 | regulation of cholesterol efflux (GO:0010874) | 2.99142902 |
| 60 | dermatan sulfate metabolic process (GO:0030205) | 2.98072669 |
| 61 | surfactant homeostasis (GO:0043129) | 2.97779929 |
| 62 | regulation of macrophage chemotaxis (GO:0010758) | 2.96462073 |
| 63 | membrane lipid catabolic process (GO:0046466) | 2.96434036 |
| 64 | dermatan sulfate biosynthetic process (GO:0030208) | 2.96137507 |
| 65 | vitamin transmembrane transport (GO:0035461) | 2.95692023 |
| 66 | regulation of macrophage cytokine production (GO:0010935) | 2.93587818 |
| 67 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.92181345 |
| 68 | regulation of heat generation (GO:0031650) | 2.89196684 |
| 69 | regulation of endothelial cell differentiation (GO:0045601) | 2.87338186 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87055623 |
| 71 | regulation of mononuclear cell migration (GO:0071675) | 2.86883471 |
| 72 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.86271186 |
| 73 | decidualization (GO:0046697) | 2.85646338 |
| 74 | import into cell (GO:0098657) | 2.85338209 |
| 75 | sphingolipid catabolic process (GO:0030149) | 2.85335592 |
| 76 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.85202284 |
| 77 | basement membrane organization (GO:0071711) | 2.84512048 |
| 78 | response to thyroid hormone (GO:0097066) | 2.82964944 |
| 79 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.82262747 |
| 80 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81320713 |
| 81 | iron ion import (GO:0097286) | 2.81264369 |
| 82 | cellular response to zinc ion (GO:0071294) | 2.79174934 |
| 83 | cGMP-mediated signaling (GO:0019934) | 2.78950002 |
| 84 | definitive hemopoiesis (GO:0060216) | 2.75696030 |
| 85 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75128532 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74668632 |
| 87 | regulation of apoptotic cell clearance (GO:2000425) | 2.74040540 |
| 88 | trabecula formation (GO:0060343) | 2.72839121 |
| 89 | cyclooxygenase pathway (GO:0019371) | 2.69664863 |
| 90 | adhesion of symbiont to host cell (GO:0044650) | 2.68314235 |
| 91 | virion attachment to host cell (GO:0019062) | 2.68314235 |
| 92 | monocyte chemotaxis (GO:0002548) | 2.68133644 |
| 93 | lymph vessel development (GO:0001945) | 2.67928173 |
| 94 | positive regulation of heat generation (GO:0031652) | 2.67900173 |
| 95 | cell migration involved in heart development (GO:0060973) | 2.67144934 |
| 96 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.66593038 |
| 97 | positive regulation of fat cell differentiation (GO:0045600) | 2.66469720 |
| 98 | opsonization (GO:0008228) | 2.66091391 |
| 99 | microglial cell activation (GO:0001774) | 2.65082108 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64204652 |
| 101 | glycosaminoglycan catabolic process (GO:0006027) | 2.63907527 |
| 102 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.62279545 |
| 103 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.62080015 |
| 104 | adhesion of symbiont to host (GO:0044406) | 2.60690325 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60131616 |
| 106 | positive regulation of lipid storage (GO:0010884) | 2.58920698 |
| 107 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.57611279 |
| 108 | macrophage activation (GO:0042116) | 2.56846994 |
| 109 | aminoglycan catabolic process (GO:0006026) | 2.56576760 |
| 110 | establishment of endothelial barrier (GO:0061028) | 2.56161196 |
| 111 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.55818726 |
| 112 | response to acidic pH (GO:0010447) | 2.55223246 |
| 113 | cell adhesion mediated by integrin (GO:0033627) | 2.54138315 |
| 114 | phagocytosis, engulfment (GO:0006911) | 2.53325609 |
| 115 | positive regulation of respiratory burst (GO:0060267) | 2.52907194 |
| 116 | regulation of complement activation (GO:0030449) | 2.52146427 |
| 117 | response to laminar fluid shear stress (GO:0034616) | 2.51274061 |
| 118 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51163796 |
| 119 | response to host immune response (GO:0052572) | 2.51163796 |
| 120 | lytic vacuole organization (GO:0080171) | 2.49998459 |
| 121 | lysosome organization (GO:0007040) | 2.49998459 |
| 122 | phagocytosis, recognition (GO:0006910) | 2.49523283 |
| 123 | endothelial cell chemotaxis (GO:0035767) | 2.49144537 |
| 124 | plasma lipoprotein particle clearance (GO:0034381) | 2.48658579 |
| 125 | N-acetylneuraminate metabolic process (GO:0006054) | 2.47612273 |
| 126 | membrane invagination (GO:0010324) | 2.47322484 |
| 127 | regulation of sequestering of triglyceride (GO:0010889) | 2.46675659 |
| 128 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.46443642 |
| 129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.46218397 |
| 130 | negative regulation of macrophage differentiation (GO:0045650) | 2.45587916 |
| 131 | collagen catabolic process (GO:0030574) | 2.45008101 |
| 132 | regulation of platelet activation (GO:0010543) | 2.44595860 |
| 133 | regulation of cholesterol esterification (GO:0010872) | 2.44367181 |
| 134 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.44090357 |
| 135 | positive regulation of interferon-alpha production (GO:0032727) | 2.43498428 |
| 136 | glucosamine-containing compound catabolic process (GO:1901072) | 2.43359441 |
| 137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.43271115 |
| 138 | endothelial tube morphogenesis (GO:0061154) | 2.42642620 |
| 139 | morphogenesis of an endothelium (GO:0003159) | 2.42642620 |
| 140 | negative regulation of protein localization to cell surface (GO:2000009) | 2.42297058 |
| 141 | positive regulation of hemostasis (GO:1900048) | 2.41128726 |
| 142 | positive regulation of blood coagulation (GO:0030194) | 2.41128726 |
| 143 | response to auditory stimulus (GO:0010996) | 2.41123023 |
| 144 | collagen metabolic process (GO:0032963) | 2.41085154 |
| 145 | amyloid precursor protein catabolic process (GO:0042987) | 2.41038332 |
| 146 | regulation of lipid kinase activity (GO:0043550) | 2.40658986 |
| 147 | negative regulation of lipid storage (GO:0010888) | 2.40517492 |
| 148 | low-density lipoprotein particle remodeling (GO:0034374) | 2.40307280 |
| 149 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.39404925 |
| 150 | regulation of protein activation cascade (GO:2000257) | 2.39115877 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.38977421 |
| 152 | sulfur compound catabolic process (GO:0044273) | 2.38845254 |
| 153 | protein heterotrimerization (GO:0070208) | 2.38088812 |
| 154 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.37413683 |
| 155 | positive regulation of receptor recycling (GO:0001921) | 2.37360163 |
| 156 | lymphangiogenesis (GO:0001946) | 2.37191021 |
| 157 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.36520552 |
| 158 | neuron projection regeneration (GO:0031102) | 2.36493420 |
| 159 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35038941 |
| 160 | blood vessel maturation (GO:0001955) | 2.34071072 |
| 161 | hyaluronan catabolic process (GO:0030214) | 2.33949682 |
| 162 | positive regulation of phagocytosis (GO:0050766) | 2.33764996 |
| 163 | tooth mineralization (GO:0034505) | 2.33647784 |
| 164 | regulation of podosome assembly (GO:0071801) | 2.32117815 |
| 165 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.31737553 |
| 166 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.31737553 |
| 167 | vitamin D metabolic process (GO:0042359) | 2.30489007 |
| 168 | lung epithelium development (GO:0060428) | 2.30216305 |
| 169 | regulation of interferon-alpha production (GO:0032647) | 2.29803487 |
| 170 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.29712695 |
| 171 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29212638 |
| 172 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.29137773 |
| 173 | response to host (GO:0075136) | 2.29137773 |
| 174 | response to host defenses (GO:0052200) | 2.29137773 |
| 175 | regulation of antigen processing and presentation (GO:0002577) | 2.28902881 |
| 176 | extracellular matrix assembly (GO:0085029) | 2.28309443 |
| 177 | craniofacial suture morphogenesis (GO:0097094) | 2.28249225 |
| 178 | neutrophil activation involved in immune response (GO:0002283) | 2.28086124 |
| 179 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.27951711 |
| 180 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.27917897 |
| 181 | regulation of vasculogenesis (GO:2001212) | 2.27433246 |
| 182 | embryo implantation (GO:0007566) | 2.26862061 |
| 183 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.25619281 |
| 184 | semaphorin-plexin signaling pathway (GO:0071526) | 2.25064666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.12255929 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97470435 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.62778003 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.62370773 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57197830 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54839106 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37538494 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.35406062 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29238530 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26729694 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20054727 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16434572 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12951780 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08396532 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06936233 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97854676 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.96537733 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96067262 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93511154 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.92283809 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90495043 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90384057 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.89034133 |
| 24 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88691094 |
| 25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86832373 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84679856 |
| 27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84457665 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82509052 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73986983 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70951279 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.67781997 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66939289 |
| 33 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.64228121 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63556118 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56965397 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56561508 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.54592591 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53311406 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.51060782 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50353521 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.49398138 |
| 42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44893373 |
| 43 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44495318 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42973048 |
| 45 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42590798 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41625953 |
| 47 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.39265770 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37148530 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34664414 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33113733 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32712093 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32617748 |
| 53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30180891 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27842392 |
| 55 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26575971 |
| 56 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26338223 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24774935 |
| 58 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23946188 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23353921 |
| 60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23075690 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21273377 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.20972813 |
| 63 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20672523 |
| 64 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20643604 |
| 65 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20643604 |
| 66 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20643604 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20117317 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19433326 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18550167 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17748679 |
| 71 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.17735824 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15274121 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15058961 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14480122 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14316925 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13921217 |
| 77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12967786 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.12464444 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12431507 |
| 80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12431507 |
| 81 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.12425541 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12351206 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12315877 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09797561 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08500657 |
| 86 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07138358 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05942398 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05288693 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04602426 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04602426 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04199065 |
| 92 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03744461 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03517889 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03285377 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02898809 |
| 96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01657032 |
| 97 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.01290195 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00657503 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98769474 |
| 100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98392275 |
| 101 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98282594 |
| 102 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97863937 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97789156 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97768138 |
| 105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97677407 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97614673 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97599011 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97063405 |
| 109 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96967181 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96905010 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96004415 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95854889 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95307751 |
| 114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95302353 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95302353 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94708857 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94594282 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94177735 |
| 119 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93888509 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93779346 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92116800 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91829986 |
| 123 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91724782 |
| 124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91238691 |
| 125 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91138833 |
| 126 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91020812 |
| 127 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89677408 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89292181 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89174039 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88559171 |
| 131 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87821778 |
| 132 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87561031 |
| 133 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87248852 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87234601 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86918782 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86865230 |
| 137 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.86252581 |
| 138 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.85952531 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85708683 |
| 140 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85326747 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85059005 |
| 142 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85057358 |
| 143 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84929068 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84634422 |
| 145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84315968 |
| 146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83978571 |
| 147 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83558708 |
| 148 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82210357 |
| 149 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82046150 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81066382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005167_abnormal_blood-brain_barrier | 4.29881777 |
| 2 | MP0003303_peritoneal_inflammation | 3.84782710 |
| 3 | MP0003011_delayed_dark_adaptation | 3.74920370 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.31537255 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.26051880 |
| 6 | MP0003724_increased_susceptibility_to | 3.22744455 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.10317112 |
| 8 | MP0003136_yellow_coat_color | 2.99275734 |
| 9 | MP0009840_abnormal_foam_cell | 2.83852680 |
| 10 | MP0002254_reproductive_system_inflammat | 2.76441638 |
| 11 | MP0009278_abnormal_bone_marrow | 2.62173580 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.58188926 |
| 13 | MP0003690_abnormal_glial_cell | 2.51993333 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.48061739 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.46415527 |
| 16 | MP0005171_absent_coat_pigmentation | 2.21048714 |
| 17 | MP0005670_abnormal_white_adipose | 2.16734982 |
| 18 | MP0001958_emphysema | 1.99676595 |
| 19 | MP0006138_congestive_heart_failure | 1.99307610 |
| 20 | MP0004272_abnormal_basement_membrane | 1.98232158 |
| 21 | MP0003075_altered_response_to | 1.94685913 |
| 22 | MP0006054_spinal_hemorrhage | 1.91195556 |
| 23 | MP0003828_pulmonary_edema | 1.91168193 |
| 24 | MP0000604_amyloidosis | 1.84690650 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.75253836 |
| 26 | MP0002419_abnormal_innate_immunity | 1.73363497 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.71182404 |
| 28 | MP0003436_decreased_susceptibility_to | 1.68590351 |
| 29 | MP0006082_CNS_inflammation | 1.67112359 |
| 30 | MP0000767_abnormal_smooth_muscle | 1.66474886 |
| 31 | MP0000343_altered_response_to | 1.63307870 |
| 32 | MP0003634_abnormal_glial_cell | 1.61947533 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.56776722 |
| 34 | MP0005508_abnormal_skeleton_morphology | 1.56195555 |
| 35 | MP0000249_abnormal_blood_vessel | 1.50790936 |
| 36 | MP0004130_abnormal_muscle_cell | 1.49679186 |
| 37 | MP0005165_increased_susceptibility_to | 1.49195196 |
| 38 | MP0005275_abnormal_skin_tensile | 1.49075373 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.49036199 |
| 40 | MP0004883_abnormal_blood_vessel | 1.48890803 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.47763208 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.44408929 |
| 43 | MP0008004_abnormal_stomach_pH | 1.44182629 |
| 44 | MP0003186_abnormal_redox_activity | 1.43986244 |
| 45 | MP0005387_immune_system_phenotype | 1.43812815 |
| 46 | MP0001790_abnormal_immune_system | 1.43812815 |
| 47 | MP0005164_abnormal_response_to | 1.43132531 |
| 48 | MP0003279_aneurysm | 1.41922008 |
| 49 | MP0000920_abnormal_myelination | 1.39031861 |
| 50 | MP0001853_heart_inflammation | 1.36087951 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35507005 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.35476099 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.34994603 |
| 54 | MP0000685_abnormal_immune_system | 1.34040855 |
| 55 | MP0005083_abnormal_biliary_tract | 1.33874352 |
| 56 | MP0005360_urolithiasis | 1.31329378 |
| 57 | MP0004510_myositis | 1.24974253 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.23480254 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.22871407 |
| 60 | MP0005166_decreased_susceptibility_to | 1.21252678 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.16941579 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.15110356 |
| 63 | MP0000751_myopathy | 1.14567380 |
| 64 | MP0005000_abnormal_immune_tolerance | 1.12522815 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.12201376 |
| 66 | MP0005025_abnormal_response_to | 1.12037605 |
| 67 | MP0003448_altered_tumor_morphology | 1.10666028 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.10478664 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.10449539 |
| 70 | MP0001542_abnormal_bone_strength | 1.09108782 |
| 71 | MP0002133_abnormal_respiratory_system | 1.07060247 |
| 72 | MP0005388_respiratory_system_phenotype | 1.07060247 |
| 73 | * MP0010329_abnormal_lipoprotein_level | 1.06784377 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.03693773 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.03620088 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.02088361 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.01857960 |
| 78 | MP0009764_decreased_sensitivity_to | 1.01111718 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.00301205 |
| 80 | MP0001984_abnormal_olfaction | 0.99642091 |
| 81 | * MP0004019_abnormal_vitamin_homeostasis | 0.98794138 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 0.97864102 |
| 83 | MP0000516_abnormal_urinary_system | 0.97864102 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.96623661 |
| 85 | MP0002933_joint_inflammation | 0.96420125 |
| 86 | MP0009785_altered_susceptibility_to | 0.95377066 |
| 87 | MP0005023_abnormal_wound_healing | 0.95294918 |
| 88 | MP0002405_respiratory_system_inflammati | 0.95247241 |
| 89 | MP0009384_cardiac_valve_regurgitation | 0.94585249 |
| 90 | MP0003091_abnormal_cell_migration | 0.92926127 |
| 91 | MP0001324_abnormal_eye_pigmentation | 0.92267882 |
| 92 | MP0005595_abnormal_vascular_smooth | 0.91359379 |
| 93 | MP0000858_altered_metastatic_potential | 0.90414364 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.90328725 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.90278178 |
| 96 | MP0001873_stomach_inflammation | 0.89758686 |
| 97 | MP0003878_abnormal_ear_physiology | 0.89361241 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.89361241 |
| 99 | MP0000733_abnormal_muscle_development | 0.89165204 |
| 100 | MP0005390_skeleton_phenotype | 0.89001641 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.88044531 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.88044531 |
| 103 | MP0003329_amyloid_beta_deposits | 0.87569711 |
| 104 | MP0001915_intracranial_hemorrhage | 0.87278984 |
| 105 | MP0001851_eye_inflammation | 0.85899639 |
| 106 | MP0001614_abnormal_blood_vessel | 0.85331588 |
| 107 | MP0003632_abnormal_nervous_system | 0.84967821 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.83619546 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.83619546 |
| 110 | MP0004484_altered_response_of | 0.83536347 |
| 111 | MP0003633_abnormal_nervous_system | 0.83183153 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.82091414 |
| 113 | MP0008260_abnormal_autophagy | 0.81940407 |
| 114 | MP0008469_abnormal_protein_level | 0.81110404 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.80734158 |
| 116 | MP0002128_abnormal_blood_circulation | 0.80488213 |
| 117 | MP0001849_ear_inflammation | 0.80354845 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.80078877 |
| 119 | MP0005253_abnormal_eye_physiology | 0.78295759 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.77240665 |
| 121 | MP0002090_abnormal_vision | 0.77049807 |
| 122 | MP0009763_increased_sensitivity_to | 0.76781351 |
| 123 | MP0002108_abnormal_muscle_morphology | 0.76032024 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.75009002 |
| 125 | MP0004858_abnormal_nervous_system | 0.73683233 |
| 126 | MP0001756_abnormal_urination | 0.73603246 |
| 127 | MP0004947_skin_inflammation | 0.73254041 |
| 128 | MP0003795_abnormal_bone_structure | 0.71317127 |
| 129 | MP0003879_abnormal_hair_cell | 0.69372034 |
| 130 | MP0002971_abnormal_brown_adipose | 0.67259525 |
| 131 | MP0005365_abnormal_bile_salt | 0.67139510 |
| 132 | MP0003631_nervous_system_phenotype | 0.63949680 |
| 133 | MP0000026_abnormal_inner_ear | 0.63156035 |
| 134 | MP0003283_abnormal_digestive_organ | 0.63130352 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.63079319 |
| 136 | MP0000750_abnormal_muscle_regeneration | 0.63078696 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.62098351 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.61465804 |
| 139 | MP0004133_heterotaxia | 0.61090942 |
| 140 | MP0000163_abnormal_cartilage_morphology | 0.59522051 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.57602204 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.56908355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.93667857 |
| 2 | Nuclear cataract (HP:0100018) | 4.91980252 |
| 3 | Complement deficiency (HP:0004431) | 4.45139581 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.36547385 |
| 5 | Glomerulonephritis (HP:0000099) | 4.31112875 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.99671764 |
| 7 | Abnormality of complement system (HP:0005339) | 3.91667224 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.91168515 |
| 9 | Increased CSF protein (HP:0002922) | 3.89568329 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.88274798 |
| 11 | Mutism (HP:0002300) | 3.79804412 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.68023536 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.50034411 |
| 14 | Esophageal varix (HP:0002040) | 3.48889564 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.41534590 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.41534590 |
| 17 | Nephritis (HP:0000123) | 3.41423554 |
| 18 | Joint hemorrhage (HP:0005261) | 3.40982651 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.26704770 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.21513608 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18691111 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18691111 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18691111 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.11056534 |
| 25 | Nasal polyposis (HP:0100582) | 3.09189085 |
| 26 | Loss of speech (HP:0002371) | 3.08213113 |
| 27 | Cerebral aneurysm (HP:0004944) | 3.00489645 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.99217805 |
| 29 | Annular pancreas (HP:0001734) | 2.98359110 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.94478587 |
| 31 | Broad metatarsal (HP:0001783) | 2.89627873 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88819152 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88819152 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88819152 |
| 35 | Petechiae (HP:0000967) | 2.85327112 |
| 36 | Polyphagia (HP:0002591) | 2.85240562 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.82085916 |
| 38 | Axonal loss (HP:0003447) | 2.81771845 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.81719213 |
| 40 | Hematochezia (HP:0002573) | 2.76598047 |
| 41 | Arterial tortuosity (HP:0005116) | 2.75114882 |
| 42 | Protrusio acetabuli (HP:0003179) | 2.67376441 |
| 43 | Vascular tortuosity (HP:0004948) | 2.63475260 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.62164318 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.55480171 |
| 46 | Myocardial infarction (HP:0001658) | 2.53826903 |
| 47 | Apathy (HP:0000741) | 2.53624332 |
| 48 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.52713665 |
| 49 | Polycythemia (HP:0001901) | 2.52018476 |
| 50 | Diminished motivation (HP:0000745) | 2.47862213 |
| 51 | Turricephaly (HP:0000262) | 2.45993472 |
| 52 | Conjunctival telangiectasia (HP:0000524) | 2.40680341 |
| 53 | Joint stiffness (HP:0001387) | 2.38988077 |
| 54 | Adactyly (HP:0009776) | 2.36468609 |
| 55 | Mesangial abnormality (HP:0001966) | 2.35776981 |
| 56 | Prolonged neonatal jaundice (HP:0006579) | 2.32887458 |
| 57 | Aortic dissection (HP:0002647) | 2.32504101 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.30686429 |
| 59 | White forelock (HP:0002211) | 2.30513214 |
| 60 | Dementia (HP:0000726) | 2.29546242 |
| 61 | Xanthomatosis (HP:0000991) | 2.26392994 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25364408 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.24910618 |
| 64 | Shallow orbits (HP:0000586) | 2.23726576 |
| 65 | Retinal atrophy (HP:0001105) | 2.22310568 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22124343 |
| 67 | Spondylolisthesis (HP:0003302) | 2.21432079 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.19688489 |
| 69 | Abnormality of the lumbar spine (HP:0100712) | 2.17926119 |
| 70 | Amyloidosis (HP:0011034) | 2.16083787 |
| 71 | Beaking of vertebral bodies (HP:0004568) | 2.13150386 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.07446978 |
| 73 | Patchy hypopigmentation of hair (HP:0011365) | 2.06764227 |
| 74 | Premature rupture of membranes (HP:0001788) | 2.05789945 |
| 75 | Aortic aneurysm (HP:0004942) | 2.02477635 |
| 76 | Thick nail (HP:0001805) | 2.01675482 |
| 77 | Disinhibition (HP:0000734) | 2.01549413 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00941356 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 2.00941356 |
| 80 | Pathologic fracture (HP:0002756) | 1.98458412 |
| 81 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97164100 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 1.96317082 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 1.95577954 |
| 84 | Poor head control (HP:0002421) | 1.94823360 |
| 85 | Hypercholesterolemia (HP:0003124) | 1.94758550 |
| 86 | Neoplasm of head and neck (HP:0012288) | 1.93178395 |
| 87 | Esophageal neoplasm (HP:0100751) | 1.93178395 |
| 88 | Mitral valve prolapse (HP:0001634) | 1.93133555 |
| 89 | Rectal prolapse (HP:0002035) | 1.92652888 |
| 90 | Tetraparesis (HP:0002273) | 1.92359343 |
| 91 | Bronchomalacia (HP:0002780) | 1.91725465 |
| 92 | Colitis (HP:0002583) | 1.90905176 |
| 93 | J-shaped sella turcica (HP:0002680) | 1.89131238 |
| 94 | Hepatosplenomegaly (HP:0001433) | 1.88764609 |
| 95 | Porencephaly (HP:0002132) | 1.86913479 |
| 96 | Gingivitis (HP:0000230) | 1.86257012 |
| 97 | Absent hand (HP:0004050) | 1.85983655 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.84545865 |
| 99 | Patent foramen ovale (HP:0001655) | 1.84178221 |
| 100 | Disproportionate tall stature (HP:0001519) | 1.84042706 |
| 101 | Metaphyseal irregularity (HP:0003025) | 1.80413529 |
| 102 | Skin nodule (HP:0200036) | 1.79128291 |
| 103 | Pulmonary artery stenosis (HP:0004415) | 1.78670397 |
| 104 | Zonular cataract (HP:0010920) | 1.78248805 |
| 105 | Cervical subluxation (HP:0003308) | 1.77339182 |
| 106 | Peripheral demyelination (HP:0011096) | 1.75396566 |
| 107 | Ulnar bowing (HP:0003031) | 1.74827742 |
| 108 | Growth hormone excess (HP:0000845) | 1.74431552 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74419441 |
| 110 | Bladder diverticulum (HP:0000015) | 1.74116821 |
| 111 | Peritonitis (HP:0002586) | 1.73880561 |
| 112 | Cerebral inclusion bodies (HP:0100314) | 1.73609339 |
| 113 | Microretrognathia (HP:0000308) | 1.73533155 |
| 114 | Diplopia (HP:0000651) | 1.72383212 |
| 115 | Abnormality of binocular vision (HP:0011514) | 1.72383212 |
| 116 | Abnormality of the vertebral endplates (HP:0005106) | 1.71430425 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.70008089 |
| 118 | Upper motor neuron abnormality (HP:0002127) | 1.69387111 |
| 119 | Recurrent skin infections (HP:0001581) | 1.69092069 |
| 120 | Ovoid vertebral bodies (HP:0003300) | 1.68917042 |
| 121 | Epidermoid cyst (HP:0200040) | 1.68397189 |
| 122 | Peripheral hypomyelination (HP:0007182) | 1.67114454 |
| 123 | Mitral stenosis (HP:0001718) | 1.66990072 |
| 124 | Purpura (HP:0000979) | 1.66655171 |
| 125 | Irregular vertebral endplates (HP:0003301) | 1.66433749 |
| 126 | Thoracic kyphosis (HP:0002942) | 1.66336214 |
| 127 | Agnosia (HP:0010524) | 1.64968614 |
| 128 | Portal hypertension (HP:0001409) | 1.64460276 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.64438731 |
| 130 | Split foot (HP:0001839) | 1.63593589 |
| 131 | Short femoral neck (HP:0100864) | 1.62810452 |
| 132 | Bone cyst (HP:0012062) | 1.62622838 |
| 133 | Tetany (HP:0001281) | 1.61549316 |
| 134 | Scapular winging (HP:0003691) | 1.60384451 |
| 135 | Persistence of primary teeth (HP:0006335) | 1.59970473 |
| 136 | Abnormal eating behavior (HP:0100738) | 1.59915653 |
| 137 | Cardiomegaly (HP:0001640) | 1.59484692 |
| 138 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.58546180 |
| 139 | Aplasia of the phalanges of the hand (HP:0009802) | 1.58546180 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.58546180 |
| 141 | Striae distensae (HP:0001065) | 1.58177823 |
| 142 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.56329551 |
| 143 | Coronal craniosynostosis (HP:0004440) | 1.55782281 |
| 144 | Choanal stenosis (HP:0000452) | 1.55393838 |
| 145 | Atelectasis (HP:0100750) | 1.54045719 |
| 146 | Aortic valve stenosis (HP:0001650) | 1.53420646 |
| 147 | Craniofacial dystonia (HP:0012179) | 1.53147370 |
| 148 | Bone pain (HP:0002653) | 1.52839073 |
| 149 | Flared iliac wings (HP:0002869) | 1.51865777 |
| 150 | Stroke (HP:0001297) | 1.51297761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 3.71256151 |
| 2 | BMX | 2.98832153 |
| 3 | GRK1 | 2.87789060 |
| 4 | CAMK1G | 2.85059070 |
| 5 | NME2 | 2.83317562 |
| 6 | TGFBR2 | 2.61941581 |
| 7 | PIM2 | 2.48409810 |
| 8 | TESK1 | 2.26041398 |
| 9 | TEC | 2.07708812 |
| 10 | BCKDK | 2.07371460 |
| 11 | TIE1 | 12.0107451 |
| 12 | TYRO3 | 1.78521469 |
| 13 | ERN1 | 1.66756283 |
| 14 | MAP3K11 | 1.58284180 |
| 15 | CDC42BPA | 1.55107174 |
| 16 | KDR | 1.49200118 |
| 17 | RIPK1 | 1.46597046 |
| 18 | MOS | 1.41185501 |
| 19 | LIMK1 | 1.39847641 |
| 20 | EPHB1 | 1.34989390 |
| 21 | LATS2 | 1.31823824 |
| 22 | TRIB3 | 1.27733699 |
| 23 | TTN | 1.27727217 |
| 24 | TYK2 | 1.25260945 |
| 25 | BLK | 1.23476945 |
| 26 | NTRK2 | 1.21919285 |
| 27 | ADRBK2 | 1.18591759 |
| 28 | TAOK1 | 1.07546954 |
| 29 | PTK6 | 1.07425275 |
| 30 | MAPK15 | 1.04300744 |
| 31 | PKN1 | 1.03869139 |
| 32 | PAK4 | 0.97345004 |
| 33 | FGFR4 | 0.96743631 |
| 34 | MYLK | 0.93823542 |
| 35 | EPHB2 | 0.92044192 |
| 36 | KIT | 0.91590555 |
| 37 | PDGFRB | 0.91465728 |
| 38 | ROCK2 | 0.90358071 |
| 39 | MST1R | 0.86172504 |
| 40 | JAK1 | 0.85932752 |
| 41 | CSK | 0.85500619 |
| 42 | LMTK2 | 0.81982931 |
| 43 | ICK | 0.80831144 |
| 44 | CSNK1G2 | 0.80434132 |
| 45 | TNIK | 0.80211630 |
| 46 | TBK1 | 0.79329034 |
| 47 | SIK1 | 0.79218771 |
| 48 | TRPM7 | 0.78985477 |
| 49 | MAP2K2 | 0.78454405 |
| 50 | ARAF | 0.75792736 |
| 51 | TESK2 | 0.75268639 |
| 52 | CAMK2G | 0.75051549 |
| 53 | RIPK4 | 0.72859500 |
| 54 | TAOK2 | 0.72174812 |
| 55 | PDGFRA | 0.68690783 |
| 56 | CSNK1G3 | 0.67293723 |
| 57 | PRKD2 | 0.66005246 |
| 58 | DAPK2 | 0.65840170 |
| 59 | EGFR | 0.62362476 |
| 60 | MARK2 | 0.62292498 |
| 61 | INSRR | 0.61850803 |
| 62 | GRK7 | 0.61339849 |
| 63 | FGR | 0.61106089 |
| 64 | CAMK2D | 0.60303404 |
| 65 | STK16 | 0.60289601 |
| 66 | ZAP70 | 0.59902966 |
| 67 | PTK2B | 0.57957060 |
| 68 | DDR2 | 0.57656158 |
| 69 | PKN2 | 0.57637510 |
| 70 | STK10 | 0.57430186 |
| 71 | MAPK4 | 0.56875386 |
| 72 | MET | 0.56585632 |
| 73 | IRAK3 | 0.55933407 |
| 74 | RPS6KA2 | 0.55002377 |
| 75 | PAK2 | 0.54365580 |
| 76 | ROCK1 | 0.54357619 |
| 77 | ERBB2 | 0.54283609 |
| 78 | LRRK2 | 0.53641471 |
| 79 | HCK | 0.53379889 |
| 80 | FES | 0.53182960 |
| 81 | MAPK7 | 0.51219030 |
| 82 | PRKCH | 0.51206688 |
| 83 | DYRK3 | 0.51147876 |
| 84 | PDPK1 | 0.50685853 |
| 85 | GSK3A | 0.50604736 |
| 86 | SGK3 | 0.49818418 |
| 87 | CSNK1G1 | 0.49416243 |
| 88 | TSSK6 | 0.49372851 |
| 89 | DAPK3 | 0.48599818 |
| 90 | MAP3K3 | 0.48388265 |
| 91 | TAOK3 | 0.48309091 |
| 92 | CAMK4 | 0.47085115 |
| 93 | CDK14 | 0.46839028 |
| 94 | PRKCE | 0.46378520 |
| 95 | DYRK1B | 0.45852886 |
| 96 | NTRK1 | 0.45301284 |
| 97 | JAK2 | 0.45047403 |
| 98 | ERBB4 | 0.43464538 |
| 99 | MAP3K14 | 0.43335969 |
| 100 | IRAK1 | 0.43093636 |
| 101 | CDK11A | 0.43055786 |
| 102 | MAP3K1 | 0.43047867 |
| 103 | SRC | 0.42630096 |
| 104 | CSNK1A1L | 0.41830128 |
| 105 | CDK15 | 0.41433349 |
| 106 | TGFBR1 | 0.41332422 |
| 107 | RPS6KC1 | 0.40994274 |
| 108 | RPS6KL1 | 0.40994274 |
| 109 | PRKAA2 | 0.40376743 |
| 110 | FGFR3 | 0.40183037 |
| 111 | MAP3K5 | 0.40099609 |
| 112 | PRKG2 | 0.39578256 |
| 113 | LYN | 0.39410587 |
| 114 | PINK1 | 0.38805531 |
| 115 | CLK1 | 0.38559671 |
| 116 | DYRK2 | 0.38384393 |
| 117 | MAPK12 | 0.38176471 |
| 118 | MAP3K6 | 0.37547942 |
| 119 | RPS6KA6 | 0.37007081 |
| 120 | INSR | 0.36532010 |
| 121 | PTK2 | 0.36222249 |
| 122 | DMPK | 0.36148394 |
| 123 | IKBKE | 0.36132176 |
| 124 | FYN | 0.36099220 |
| 125 | SGK2 | 0.35525291 |
| 126 | PRKD1 | 0.35019659 |
| 127 | IGF1R | 0.34629798 |
| 128 | EPHA3 | 0.34337868 |
| 129 | CAMKK1 | 0.34242299 |
| 130 | MAPKAPK3 | 0.34190143 |
| 131 | NEK9 | 0.33432899 |
| 132 | IKBKB | 0.31819790 |
| 133 | IRAK4 | 0.31188302 |
| 134 | MAPKAPK2 | 0.31124356 |
| 135 | MAP4K1 | 0.30457140 |
| 136 | MAP3K12 | 0.30415790 |
| 137 | MAP2K1 | 0.30343900 |
| 138 | ABL1 | 0.30315406 |
| 139 | PRKCG | 0.30178548 |
| 140 | PRKCD | 0.29650776 |
| 141 | FER | 0.29118250 |
| 142 | FGFR2 | 0.26962691 |
| 143 | CSF1R | 0.26142879 |
| 144 | MATK | 0.25710095 |
| 145 | ABL2 | 0.25172939 |
| 146 | CDK6 | 0.24367195 |
| 147 | PRPF4B | 0.23918593 |
| 148 | ITK | 0.23730120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.07247551 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.30677344 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73307225 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43670873 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.31378754 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.24074096 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.17255878 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05171786 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98207882 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93213034 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.79258174 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.69053151 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.62860847 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.60044561 |
| 15 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58986954 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.54643230 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53974882 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49893493 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.47223825 |
| 20 | Prion diseases_Homo sapiens_hsa05020 | 1.33009403 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32931504 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31645923 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26643328 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25222994 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.22247269 |
| 26 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21451903 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.20744719 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19587438 |
| 29 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.19528020 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19238176 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15726317 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15471370 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14310049 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.09933095 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.06333135 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04527426 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 0.97136857 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 0.95417991 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94361960 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93756851 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93621779 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92633381 |
| 43 | Asthma_Homo sapiens_hsa05310 | 0.92014772 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 0.90187071 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89575204 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88461643 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87870049 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.87745285 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87199753 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86665184 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86218831 |
| 52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85659643 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83637631 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83302904 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.82095662 |
| 56 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80512906 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76972685 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76032912 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.75312942 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74914232 |
| 61 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74709513 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73590035 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72115063 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72032050 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70592149 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70161717 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68362115 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67553884 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.67431619 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.67356710 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66045692 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.65311561 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64859515 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64693335 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64337219 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64270569 |
| 77 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63488231 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63440451 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62815731 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62618006 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62256560 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61725772 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60608808 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60574243 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60507941 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59943803 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59933169 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58762241 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58293514 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58187836 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57864246 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56890696 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56556227 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56220353 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.56021960 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54908672 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54525376 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52273702 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.50671672 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50557196 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49961216 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49643990 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48934263 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48857313 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48489879 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47868726 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47335172 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46569613 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46456023 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46239546 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46191695 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45596025 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45531311 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.45027177 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44329786 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44195030 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43344330 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42909471 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41938866 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41902545 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41014034 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40378557 |
| 123 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40214812 |
| 124 | Melanogenesis_Homo sapiens_hsa04916 | 0.37315940 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.37089697 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36502050 |
| 127 | Influenza A_Homo sapiens_hsa05164 | 0.36429827 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36253595 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.34574329 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34220770 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31626198 |
| 132 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30646422 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28393148 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27118171 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26936061 |
| 136 | Axon guidance_Homo sapiens_hsa04360 | 0.26653722 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22144473 |
| 138 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21922192 |
| 139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21009915 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.20056019 |

